Stocks / Pharmaceuticals
SLSPharmaceuticals
SELLAS Life Sciences Group, Inc.
$11.481d -1.5%5d -15.0%settled close · 2026-09-17
Mkt cap $897M (3/25)β 2.3652w $4.55–15.75Shares 179.6MInd. Pharmaceutical PreparationsNasdaq since 2008Emp. 13HQ New York, NYsellaslifesciences.com
Who’s talkingIdea Scout · free
Who’s talking about SLS
No tracked investor commentary on SLS yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 10 Nov 2026
Confirmed date · consensus EPS -0.05. Reactions below are the next settled session over the prior close.
| Report | When | EPS actual vs est. | Reaction |
|---|---|---|---|
| 11 Aug 2026 | after the close | -0.05 vs -0.05 | +6.7% |
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where SLS’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 9 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-08-21 | ||||||
| 2026-08-19 | ||||||
| 2026-08-12 | ||||||
| 2026-07-13 | ||||||
| 2026-06-29 | ||||||
| 2026-06-26 | ||||||
| 2026-06-25 | ||||||
| 2026-05-29 | ||||||
| 2026-05-20 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
SLS is in this morning’s Brief.
Get The Brief — $20/mo →